Expanded Access Program With Lanadelumab for Japanese People With Hereditary Angioedema

NCT04687137 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
12
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Takeda